Design the synthesis of AIEgen photosensitizers for regulating the level of PTX in drug-resistant tumor cells
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. The role of photodynamic therapy in overcoming cancer drug resistance10.1039/c4pp00495g ↗
2. A multi-action and multi-target ruii–ptiv conjugate combining cancer-activated chemotherapy and photodynamic therapy to overcome drug resistant cancers10.1002/anie.201916400 ↗
3. Drug delivery micelles with efficient near-infrared photosensitizer for combined image-guided photodynamic therapy and chemotherapy of drug-resistant cancer10.1016/j.biomaterials.2019.119330 ↗
4. Mechanisms of resistance to photodynamic therapy10.2174/092986711795843272 ↗
5. The role of photodynamic therapy on multidrug resistant breast cancer10.1186/s12935-019-0815-0 ↗
6. Nanotechnology applied to overcome tumor drug resistance10.1016/j.jconrel.2012.05.051 ↗
7. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology10.1016/j.jconrel.2011.03.032 ↗
8. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT10.1016/j.jphotobiol.2009.04.001 ↗
9. A review of chemotherapy and photodynamic therapy for lung cancer treatment10.2174/1871520620666200403144945 ↗
10. Overview of nanoparticle-based approaches for the combination of photodynamic therapy (pdt) and chemotherapy at the preclinical stage10.3390/cancers14184462 ↗
11. Advances in nanomaterials for photodynamic therapy applications: status and challenges10.1016/j.biomaterials.2020.119827 ↗
12. Enhanced photodynamic therapy for overcoming tumor hypoxia: from microenvironment regulation to photosensitizer innovation10.1016/j.ccr.2020.213604 ↗
13. Protease-responsive prodrug with aggregation-induced emission probe for controlled drug delivery and drug release tracking in living cells10.1021/acs.analchem.6b02833 ↗
14. Biomacromolecule-functionalized AIEgens for advanced biomedical studies10.1002/smll.201804839 ↗
15. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
16. Photodynamic therapy of cancer — challenges of multidrug resistance
17. Advances in photosensitizer-related design for photodynamic therapy
18. Photosensitizers for photodynamic therapy10.1002/adhm.201900132 ↗
19. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
20. Recent advances in activatable organic photosensitizers for specific photodynamic therapy10.1002/cplu.202000203 ↗
21. Specific light-up bioprobe with aggregation-induced emission and activatable photoactivity for the targeted and image-guided photodynamic ablation of cancer cells10.1002/anie.201408476 ↗
22. A Highly efficient and photostable photosensitizer with near-infrared aggregation-induced emission for image-guided photodynamic anticancer therapy10.1002/adma.201700548 ↗
23. One-step formulation of targeted aggregation-induced emission dots for image-guided photodynamic therapy of cholangiocarcinoma10.1021/acsnano.7b00312 ↗
24. Photosensitizers with aggregation-induced emission: materials and biomedical applications10.1002/adma.201801350 ↗
25. Recent advances in aiegen-based photodynamic therapy and immunotherapy10.1002/adhm.202101066 ↗
26. Highly efficient singlet oxygen generation, two-photon photodynamic therapy and melanoma ablation by rationally designed mitochondria-specific near-infrared AIEgens10.1039/C9SC06441A ↗
27. Recent advances in stimuli-responsive theranostic systems with aggregation-induced emission characteristics10.1002/agt2.10 ↗
28. A high therapeutic efficacy of polymeric prodrug nano-assembly for a combination of photodynamic therapy and chemotherapy10.1038/s42003-018-0204-6 ↗
29. AIEgens for microbial detection and antimicrobial therapy10.1016/j.biomaterials.2020.120598 ↗
30. A novel drug susceptibility testing AIEgen with spatiotemporal resolved progress-reporting characteristic for therapy of drug-resistant tumor10.1016/j.mattod.2022.06.008 ↗
31. Light-responsive AIE nanoparticles with cytosolic drug release to overcome drug resistance in cancer cells10.1039/C6PY00449K ↗
32. An amphiphilic tetraphenylethylene-based photosensitizer for cancer cell ablation and bacteria killing10.1016/j.dyepig.2022.110652 ↗
33. AIE based GSH activatable photosensitizer for imaging-guided photodynamic therapy10.1039/D0CC02045A ↗
34. Tunning intermolecular interaction of peptide-conjugated aiegen in nano-confined space for quantitative detection of tumor marker secreted from cells10.1021/acs.analchem.1c04422 ↗
35. Modular-peptides-based ternary complex for precisely tracking the targeted process and delivery of gene/chemo-drug10.1002/adom.202100966 ↗
36. Tumor-triggered disassembly of a multiple-agent-therapy probe for efficient cellular internalization10.1002/anie.202009196 ↗
37. Multifunctional AIEgens for future theranostics10.1002/smll.201601637 ↗
38. Cancer multidrug resistance10.1038/5289 ↗